Search by Drug Name or NDC
NDC 63323-0579-05 SINCALIDE 5 ug/5mL Details
SINCALIDE 5 ug/5mL
SINCALIDE is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is SINCALIDE.
Product Information
NDC | 63323-0579 |
---|---|
Product ID | 63323-579_efc423ee-f932-45d4-9fd2-d4b4c350f5db |
Associated GPIs | |
GCN Sequence Number | 003097 |
GCN Sequence Number Description | sincalide VIAL 5 MCG INJECTION |
HIC3 | D7B |
HIC3 Description | CHOLERETICS |
GCN | 09830 |
HICL Sequence Number | 001372 |
HICL Sequence Number Description | SINCALIDE |
Brand/Generic | Generic |
Proprietary Name | SINCALIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | sincalide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 5 |
Active Ingredient Units | ug/5mL |
Substance Name | SINCALIDE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | Cholecystokinin Analog [EPC], Cholecystokinin [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA017697 |
Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0579-05 (63323057905)
NDC Package Code | 63323-579-05 |
---|---|
Billing NDC | 63323057905 |
Package | 10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01) |
Marketing Start Date | 2023-04-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |